Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Silverback Therapeutics, Inc. (SPRY).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 18 Mar 2022, 17:14.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Purchase
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
| Id | Content |
|---|---|
| F1 | Shares are being reported following the discovery that shares of the issuer were purchased in discretionary IRA accounts held by the spouse of the reporting person. The reporting person is not an owner of such IRA accounts. The total in Column 5 of Table I does not reflect previously reported transactions that occurred after 3/3/2021. |
| F2 | Presidio Management Group XII, L.L.C. (PMG XII), the general partner of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, USVP XII), has sole voting and dispositive power with respect to the shares held by USVP XII. The reporting person is a managing member of PMG XII, and shares voting and dispositive power with respect to the shares held by USVP XII. The reporting person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares. |